Catalyst Wire Dossier Catalyst Wire Dossier

HYRNUO

SEVABERTINIB · Bayer HealthCare Pharmaceuticals Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HYRNUO, covering 2025-11-19 to 2025-11-19. Get the full timeline:

Most recent: FDA Approved: HYRNUO — Original Application (Bayer HealthCare Pharmaceuticals Inc.)

See pricing